CA2409342A1 - Messagers extracellulaires - Google Patents

Messagers extracellulaires Download PDF

Info

Publication number
CA2409342A1
CA2409342A1 CA002409342A CA2409342A CA2409342A1 CA 2409342 A1 CA2409342 A1 CA 2409342A1 CA 002409342 A CA002409342 A CA 002409342A CA 2409342 A CA2409342 A CA 2409342A CA 2409342 A1 CA2409342 A1 CA 2409342A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
seq
xmes
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002409342A
Other languages
English (en)
Inventor
Preeti Lal
Henry Yue
Ann He
Danniel B. Nguyen
Narinder K. Chawla
Ameena R. Gandhi
Yalda Azimzai
Olga Bandman
Y. Tom Tang
Yan Lu
Mariah R. Baughn
Brendan M. Duggan
Sally Lee
April Hafalia
Jennifer L. Policky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2409342A1 publication Critical patent/CA2409342A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des messagers extracellulaires (XMES) humains et des polynucléotides qui identifient et codent pour XMES. L'invention concerne aussi des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne de plus des procédés permettant de diagnostiquer, de traiter ou de prévenir des affections associées à une expression aberrante de XMES.
CA002409342A 2000-06-06 2001-06-06 Messagers extracellulaires Abandoned CA2409342A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US21023300P 2000-06-06 2000-06-06
US60/210,233 2000-06-06
US21346500P 2000-06-23 2000-06-23
US60/213,465 2000-06-23
US24901900P 2000-11-14 2000-11-14
US60/249,019 2000-11-14
PCT/US2001/018476 WO2001094587A2 (fr) 2000-06-06 2001-06-06 Messagers extracellulaires

Publications (1)

Publication Number Publication Date
CA2409342A1 true CA2409342A1 (fr) 2001-12-13

Family

ID=27395465

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002409342A Abandoned CA2409342A1 (fr) 2000-06-06 2001-06-06 Messagers extracellulaires

Country Status (5)

Country Link
EP (1) EP1287141A2 (fr)
JP (1) JP2004515216A (fr)
AU (1) AU2001266765A1 (fr)
CA (1) CA2409342A1 (fr)
WO (1) WO2001094587A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040010118A1 (en) * 2000-08-16 2004-01-15 Zerhusen Bryan D. Novel proteins and nucleic acids encoding same
EP2270163A1 (fr) 2003-12-10 2011-01-05 Eli Lilly and Company Mutéines du facteur de croissance des fibroblastes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039123A2 (fr) * 1996-04-18 1997-10-23 Genetics Institute, Inc. Proteines secretees
EP1151101A4 (fr) * 1998-12-18 2002-10-09 Human Genome Sciences Inc Facteur-2 stimulant de prostacycline
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6822082B2 (en) * 2000-06-30 2004-11-23 Zymogenetics, Inc. Polynucleotides for mammalian secreted protein, Z1055G2P

Also Published As

Publication number Publication date
AU2001266765A1 (en) 2001-12-17
JP2004515216A (ja) 2004-05-27
EP1287141A2 (fr) 2003-03-05
WO2001094587A2 (fr) 2001-12-13
WO2001094587A3 (fr) 2002-12-27

Similar Documents

Publication Publication Date Title
CA2408315A1 (fr) Aminoacyl-arnt synthetases
CA2431493A1 (fr) Aminoacyl arnt synthetases
EP1196575A2 (fr) Proteines associees de liaison gtp
US20050079538A1 (en) Secreted proteins
US20040018499A1 (en) Extracellular messengers
CA2410953A1 (fr) Adenylyl et guanylyl cyclases
US20020160950A1 (en) Cytochrome P450 variant
WO2002004611A2 (fr) Aminoacyl arnt synthetases
CA2410679A1 (fr) Molecules de circulation et de secretion
CA2397334A1 (fr) Proteines secretees
CA2409342A1 (fr) Messagers extracellulaires
WO2002048362A2 (fr) Proteines associees a l'embryogenese
CA2336262A1 (fr) Tri de nexines
WO2002046413A2 (fr) Molecules pour la detection et le traitement de maladies
CA2402747A1 (fr) Molecules associees a la proteine g
CA2381338A1 (fr) Lyases humaines
CA2431144A1 (fr) Proteines d'adhesion cellulaire
CA2430906A1 (fr) Proteines associees a la croissance, a la differenciation et a la mort cellulaire
CA2433843A1 (fr) Molecules utiles pour detecter et traiter des maladies
CA2425767A1 (fr) Lipocalines
CA2375407A1 (fr) Proteines du metabolisme de l'arn
CA2417676A1 (fr) Sequences pour l'integrine alpha-8
CA2378930A1 (fr) Proteines de transfert d'electrons
US20040023251A1 (en) Cell cycle proteins and mitosis-associated molecules
CA2415077A1 (fr) Proteines du cycle cellulaire et molecules associees a la mitose

Legal Events

Date Code Title Description
FZDE Dead